Skip to main content
. 2022 May 26;11(24):4756–4766. doi: 10.1002/cam4.4802

FIGURE 1.

FIGURE 1

Race‐stratified biochemical recurrence‐free (A), distant metastasis‐free (B), and overall survival (C) in low‐risk patients. Study outcomes were modeled as time‐to‐event endpoints using race‐stratified Kaplan–Meier estimation curves. Low and favorable‐intermediate risk strata were defined by National Comprehensive Cancer Network criteria. 21 AA, African American; CA, Caucasian American; BCR, biochemical recurrence; DM, distant metastasis; OS, overall survival